References
- Skelly J. P., Van Burskirk G. A., Savello D. R., Amidon G. L., Arbit H. M., Dighe S., Fawzi M. B., Gonzalez M. A., Malick A. W., Malinowski H., Nedich R., Peck G. E., Pearce D. M., Shah V., Shangraw R. F., Schwartz J. B., Truelove J. Workshop report: Scaleup of immediate release oral solid dosage forms. Pharm. Res 1993; 10(2)313–316
- Immediate release solid oral dosage forms, Scale-up and post-approval changes: Chemistry, manufacturing, and controls; in vitro dissolution testing; in vivo Inequivalence documentation; Guidance. Fed. Reg 1995; 60(230)61638–61643
- Amidon G. L., Lennernas H., Shah V. P., Crison J. R. A theoretical basis for a biopharmaceutical drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res 1995; 12(3)413–420
- Augsburger L. L., Shangraw R. F., Lesko L. J., Williams R. L. An approach toward establishing a scientific foundation for interpreting regulations and workshop on scale-up and post approval changes. Pharm. Res 1994; 11(10)S-143
- Lennard M. S., Tucker G. T., Silas J. H., Woods H. F. Debrisoquine polymorphism and the metobolism action of metoprolol, timolol, propranolol and atenolol. Xenobiotica 1986; 16(5)435–447
- Lopressor®. Physician's Desk Reference. Medical Economics Data Production Co., Montvale, NJ 1994; 986–988
- Rekhi G. S., Demarest D. A., Jr., Augsburger L. L., Schwartz P., Lesko L. J. Evaluation of critical formulation and processing variables for metoprolol tartrate tablets using high-shear granulation—I. Pharm. Res 1993; 10(10)S-134
- Li J. Z., Rekhi G. S., Augsburger L. L., Shangraw R. F. The role of intra- and extragranular microc-rystalline cellulose on tablet dissolution. Pharm. Dev. Tech 1996; 1(4)343–355
- Martin A., Bustamante P., Chun A. H. C. Physical Pharmacy4th ed. Lea & Febiger, Philadelphia, PA 1993; 426–430
- Fahmy R., Krikorian S. E. Specifications of assay methods for content uniformity testing of drug dosage units: The case of metoprolol tartrate tablets. Pharmacopeial Forum 1994; 20(3)7521–7522
- USP XXII/NF XVII. United States Pharmacopeial Convention, Rockville, MD 1990
- Hildenbrand M., Seifert W., Reichenberger A. Determination of dextromethorphan metabolizer pheno-type in healthy volunteers. Eur. J. Clin. Pharmacol 1989; 36(3)315–318
- Guidance on statistical procedures for bioequivalence studies using a standard two-treatment crossover design, FDA, Office of Generic Drugs (OGD). Division of Bioequivlence, Rockville, MD 1992
- Haaland P. D. Experimental Design in Biotechnology. Marcel Dekker, New York 1989
- Rekhi G. S., Caricofe R. B., Parikh D. M., Augsburger L. L. A new approach to scale-up of a high-shear granulation process, Tableting and Granulation Yearbook. Pharm. Tech October, 1996; 58–67, Supplement